X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11235) 11235
Book Review (1854) 1854
Publication (1395) 1395
Government Document (123) 123
Book Chapter (107) 107
Conference Proceeding (50) 50
Dissertation (32) 32
Magazine Article (20) 20
Book / eBook (7) 7
Web Resource (7) 7
Trade Publication Article (4) 4
Data Set (3) 3
Streaming Video (2) 2
Journal / eJournal (1) 1
Newspaper Article (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9048) 9048
index medicus (9045) 9045
female (7449) 7449
oncology (5047) 5047
breast neoplasms - genetics (4963) 4963
breast cancer (4602) 4602
mutation (4305) 4305
brca2 (3691) 3691
middle aged (3684) 3684
genes, brca2 (3561) 3561
genes, brca1 (3558) 3558
adult (3522) 3522
cancer (2943) 2943
genetic predisposition to disease (2756) 2756
brca1 (2749) 2749
ovarian neoplasms - genetics (2581) 2581
brca2 protein - genetics (2491) 2491
aged (2359) 2359
genetic aspects (2356) 2356
risk factors (2322) 2322
ovarian-cancer (2219) 2219
ovarian cancer (2205) 2205
women (2170) 2170
brca1 protein - genetics (2031) 2031
risk (1985) 1985
brca2 protein (1863) 1863
genetics & heredity (1841) 1841
male (1723) 1723
breast-cancer (1541) 1541
research (1524) 1524
genetic testing (1494) 1494
genes (1437) 1437
gene mutations (1149) 1149
health aspects (1141) 1141
mutations (1126) 1126
germ-line mutation (1119) 1119
genetics (1107) 1107
breast neoplasms - pathology (976) 976
brca1 protein (964) 964
brca2 mutations (945) 945
heterozygote (934) 934
dna repair (931) 931
article (912) 912
breast neoplasms - epidemiology (904) 904
neoplasm proteins - genetics (901) 901
germline mutations (899) 899
skin and connective tissue diseases (887) 887
breast neoplasms - diagnosis (878) 878
animals (856) 856
breast (852) 852
genetic counseling (845) 845
risk assessment (840) 840
susceptibility (839) 839
transcription factors - genetics (837) 837
prognosis (815) 815
analysis (810) 810
aged, 80 and over (802) 802
carriers (793) 793
medicine & public health (786) 786
pedigree (783) 783
breast neoplasms - prevention & control (782) 782
tumors (774) 774
brca2 mutation carriers (765) 765
obstetrics & gynecology (755) 755
biochemistry & molecular biology (748) 748
homologous recombination (743) 743
surgery (731) 731
gene (708) 708
families (704) 704
diagnosis (700) 700
genetic screening (686) 686
carcinoma (668) 668
prevalence (638) 638
dna mutational analysis (634) 634
abridged index medicus (632) 632
care and treatment (631) 631
dna damage (630) 630
endocrine system diseases (630) 630
epidemiology (622) 622
cell biology (616) 616
population (616) 616
family-history (615) 615
survival (593) 593
oncology, experimental (589) 589
brca (576) 576
genetic research (572) 572
case-control studies (571) 571
brca2 protein - metabolism (567) 567
young adult (567) 567
mastectomy (553) 553
hereditary breast (548) 548
prevention (548) 548
dna (545) 545
deoxyribonucleic acid--dna (530) 530
mutation - genetics (515) 515
proteins (513) 513
ovarian neoplasms - prevention & control (511) 511
chemotherapy (508) 508
mutation carriers (500) 500
health risk assessment (493) 493
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (10898) 10898
French (187) 187
German (103) 103
Spanish (59) 59
Japanese (54) 54
Chinese (49) 49
Czech (44) 44
Russian (33) 33
Polish (22) 22
Korean (16) 16
Dutch (10) 10
Hungarian (8) 8
Hebrew (7) 7
Italian (7) 7
Bulgarian (6) 6
Croatian (5) 5
Danish (5) 5
Portuguese (5) 5
Swedish (4) 4
Persian (2) 2
Turkish (2) 2
Arabic (1) 1
Finnish (1) 1
Icelandic (1) 1
Latvian (1) 1
Norwegian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer, ISSN 0008-543X, 01/2017, Volume 123, Issue 2, pp. 210 - 218
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2019, Volume 381, Issue 7, pp. 690 - 690
BRCA2 in Ovarian Development and Function (N Engl J Med 2019;380:1086-1087). An author of the letter by Turchetti et al. (page 1087) was omitted: Alfonso... 
BRCA2 protein
Journal Article
Nature, ISSN 0028-0836, 04/2005, Volume 434, Issue 7035, pp. 913 - 917
Journal Article
Nature Structural & Molecular Biology, ISSN 1545-9993, 10/2010, Volume 17, Issue 10, pp. 1247 - 1254
Inherited mutations in human PALB2 are associated with a predisposition to breast and pancreatic cancers. PALB2's tumor-suppressing effect is thought to be... 
POLY(ADP-RIBOSE) POLYMERASE | COMPLEX | BIOCHEMISTRY & MOLECULAR BIOLOGY | DOUBLE-STRAND BREAKS | HISTONE H2AX | FANCONI-ANEMIA | CELL BIOLOGY | RAD51 | BIOPHYSICS | IN-VIVO | SUSCEPTIBILITY GENE | D-LOOP FORMATION | DNA-REPAIR | Recombination, Genetic - physiology | DNA, Neoplasm - metabolism | Humans | Neoplasm Proteins - physiology | DNA Repair - physiology | Molecular Sequence Data | Structure-Activity Relationship | DNA Breaks, Double-Stranded | BRCA2 Protein - physiology | Breast Neoplasms - metabolism | Base Sequence | Tumor Suppressor Proteins - chemistry | Tumor Suppressor Proteins - genetics | Female | Protein Interaction Domains and Motifs | Nuclear Proteins - genetics | Nucleic Acid Conformation | Fanconi Anemia Complementation Group N Protein | Peptide Fragments - metabolism | Neoplasm Proteins - chemistry | Nuclear Proteins - chemistry | Poly(ADP-ribose) Polymerase Inhibitors | Protein Interaction Mapping | Tumor Suppressor Proteins - physiology | Peptide Fragments - chemistry | Apoptosis Regulatory Proteins | Models, Biological | Rad51 Recombinase - chemistry | Rad51 Recombinase - physiology | BRCA2 Protein - chemistry | Nuclear Proteins - physiology | Poly (ADP-Ribose) Polymerase-1 | Breast cancer | Genetic aspects | Research | BRCA mutations | Ovarian cancer | Proteins | Mutation | Molecular biology | Prostate cancer | Index Medicus | homologous recombination | BRCA2 | PALB2
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2015, Volume 137, Issue 3, pp. 386 - 391
Abstract Background Veliparib is a potent small molecule inhibitor of PARP-1/2, which is cytotoxic in tumor cells with deficiencies in BRCA1 or BRCA2 . We... 
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | BRCA1, BRCA2 mutation | Toxicity | Veliparib | PARP inhibitor | Phase II trial | Ovarian cancer | SENSITIVITY | OPEN-LABEL | COMBINATION | PLATINUM-FREE INTERVAL | SOMATIC MUTATIONS | OBSTETRICS & GYNECOLOGY | OLAPARIB | ONCOLOGY | RESISTANCE | HOMOLOGOUS RECOMBINATION | REFRACTORY SOLID TUMORS | POLY(ADP-RIBOSE) POLYMERASE INHIBITOR | Humans | Middle Aged | Neoplasm Recurrence, Local - drug therapy | Ovarian Neoplasms - genetics | BRCA1 Protein - genetics | Neoplasms, Glandular and Epithelial - genetics | Peritoneal Neoplasms - drug therapy | Peritoneal Neoplasms - genetics | Fallopian Tube Neoplasms - genetics | Neoplasms, Glandular and Epithelial - drug therapy | Aged, 80 and over | Carcinoma, Ovarian Epithelial | Genes, BRCA2 | Germ-Line Mutation | Adult | Female | Neoplasm Recurrence, Local - genetics | Aged | Genes, BRCA1 | Benzimidazoles - adverse effects | Ovarian Neoplasms - drug therapy | BRCA2 Protein - genetics | Benzimidazoles - therapeutic use | Fallopian Tube Neoplasms - drug therapy | Medical research | Cancer patients | Care and treatment | Gene mutations | Analysis | Medicine, Experimental | Genetic aspects | Cancer | Chemotherapy | Clinical trials | Index Medicus | toxicity | BRCA2 mutation | ovarian cancer | veliparib | BRCA1
Journal Article
European Journal of Human Genetics, ISSN 1018-4813, 11/2014, Volume 22, Issue 11, pp. 1305 - 1313
Journal Article
Cancer Cell, ISSN 1535-6108, 07/2012, Volume 22, Issue 1, pp. 106 - 116
Journal Article